RxDoctor Payments Data

Robert Gertge, PA

Physician Assistant · Layton, UTNPI 1356402374

Payments from drug & device makers

$3,656in general payments, 2019–2025

Across 211 payments — averaging $17.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$935
  • Amgen$219
  • Johnson & Johnson$199
  • Neurocrine Biosciences, Inc.$183
  • Pfizer$137
  • Astellas Pharma US Inc$128
  • plus $2K from 43 others

What the payments were for

  • Food & beverage$3,57198%
  • Education$852%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,656 in reported general payments places this provider in the 90th percentile of 1,543 physician assistant providers in Utah.

See all physician assistant providers in Utah

Medicare billing

Part B allowed, 2024
$44,453
Medicare patients
121
Services billed
9,354

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban12$14,193
MounjaroTirzepatide12$12,600
EliquisApixaban21$12,146
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$9,947
LinzessLinaclotide12$6,200
FarxigaDapagliflozin Propanediol11$6,024
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen109$3,922
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine61$2,099
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen62$1,948
Oxycodone Hcl88$1,884
Diclofenac Sodium22$1,138
HumalogInsulin Lispro16$1,041
Levothyroxine Sodium63$1,024
Celecoxib34$987
Omeprazole39$923

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$199$14,19312 claims
Lilly USA, LLCMounjaro, Humalog$57$13,64128 claims
PfizerEliquis$137$12,14621 claims
GSKTrelegy Ellipta$84$9,94716 claims
AbbVieLinzess$935$6,20012 claims
AstraZenecaFarxiga$64$6,02411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,543 physician assistant providers in Utah.

Other physician assistant in Layton

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →